Journal of women's health (2002)最新文献

{"title":"Uncounted and Underserved: Housing Data and Programs Overlook Pregnant and Parenting Families.","authors":"Lauren Sayah, Emilie Glass, Katherine A Craemer, Stacie Geller","doi":"10.1177/15409996261423854","DOIUrl":"10.1177/15409996261423854","url":null,"abstract":"<p><strong>Background: </strong>Experiencing housing insecurity and homelessness while pregnant is associated with an array of adverse maternal and infant health outcomes. This study aims to describe how the federal and Illinois housing landscapes prioritize, fund, and collect data on pregnant and postpartum people.</p><p><strong>Methods: </strong>Homelessness and housing programs and services were identified through a scan and consolidation of various housing programs and services in Illinois. The homelessness and housing programs and services were organized by primary funder and then examined to determine how they prioritize, serve, and collect data on pregnant and postpartum people and families.</p><p><strong>Results: </strong>Findings suggest that both federal and state funded and monitored housing programs do not prioritize pregnant and postpartum people and families, mostly do not have specific services for pregnant and postpartum people and families, and do not systemically collect data on pregnant and postpartum people and families.</p><p><strong>Discussion: </strong>The Federal housing landscape does not currently service, prioritize, or collect data on pregnant and postpartum families experiencing homelessness and housing insecurity. Illinois serves as an example of how the Federal landscape impacts a state's housing landscape in not being organized to support and collect data on pregnant and postpartum families. However, there are several national and state data and policy opportunities to start to meet the needs of this population.</p>","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"602-607"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146215251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cesarean Rates in Epilepsy: What the Data Reveal and What They Don't.","authors":"Paula E Voinescu","doi":"10.1177/15409996261428491","DOIUrl":"10.1177/15409996261428491","url":null,"abstract":"","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"521-522"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147319160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Treatment Utilization after Uterine Fibroid Diagnosis by Race and Ethnicity.","authors":"Susanna D Mitro, Wendy Dyer, Lana Wang, Catherine Lee, Monique M Hedderson, Eve Zaritsky","doi":"10.1177/15409996261420987","DOIUrl":"10.1177/15409996261420987","url":null,"abstract":"<p><strong>Background: </strong>Treatment utilization after the first fibroid diagnosis has not been well described for patients who are not Black or White. We studied treatment utilization by race and ethnicity in a large, diverse patient cohort.</p><p><strong>Materials and methods: </strong>In the electronic health records of Kaiser Permanente Northern California, we studied 84,206 female patients aged 18-54 from first fibroid diagnosis (January 1, 2009-December 31, 2022) for up to 5 years and ascertained treatments received (levonorgestrel intrauterine device [IUD], hysteroscopic myomectomy, myomectomy, uterine artery embolization, endometrial ablation, hysterectomy). Cox proportional hazards models calculated hazard ratios for receiving any long-term treatment, uterine-preserving treatment, and hysterectomy by race and ethnicity. We assessed effect modification by body mass index (BMI), Neighborhood Deprivation Index (NDI), symptoms, and age. Finally, we calculated the hazard of receiving each treatment as the first treatment.</p><p><strong>Results: </strong>Overall, 30,838 of 84,206 patients (37%) received 36,115 treatments. The most common treatments were hysterectomy (45% of treatments), levonorgestrel IUD (21%), and myomectomy (15%). Compared with White patients, Black, Asian, and Hispanic patients were significantly less likely to receive any treatment, hysterectomy, or uterine-preserving treatment. This pattern was consistent across age, symptoms, BMI, and NDI. As first treatments, Black patients were more likely than White patients to receive uterine artery embolization, and Black, East Asian, and South Asian patients were more likely to receive myomectomy. White patients were more likely to receive hysteroscopic myomectomy, IUD, endometrial ablation, and hysterectomy as first treatments.</p><p><strong>Conclusions: </strong>Determining causes of differences in long-term treatment utilization may ensure that access to fibroid care is equitable.</p>","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"532-541"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13065105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147438974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Contraceptive Counseling Quality and Postpartum Contraceptive Method Satisfaction: A Multi-Institutional Cross-Sectional Analysis.","authors":"Nicole Luche, Elizabeth A Mosley, Nikki Zite, Kaleab Z Abebe, Michaella Wu, Christine Dehlendorf, Sonya Borrero","doi":"10.1177/15409996261449180","DOIUrl":"https://doi.org/10.1177/15409996261449180","url":null,"abstract":"<p><strong>Objectives: </strong>High-quality contraceptive counseling has been associated with increased contraceptive method satisfaction. We aimed to assess this relationship in the postpartum period and to investigate practical aspects of counseling underlying this association.</p><p><strong>Study design: </strong>We used data from 219 pregnant individuals aged 21-44 years contemplating tubal sterilization who were recruited to a randomized trial assessing the efficacy of the <i>MyDecision/MiDecisión</i> decision aid. Three months postpartum, participants rated their satisfaction with their chosen contraceptive method and their perception of contraceptive counseling encounter quality on Likert scales. Counseling quality domains included provider demonstration of respect, explanation of methods, pressure toward a method, and response to questions, as well as subjective counseling satisfaction. We used logistic regression analyses to assess the relationship between optimal counseling (both overall and in each domain) and optimal contraceptive method satisfaction, adjusting for randomization arm and demographic covariates significant in bivariate analysis.</p><p><strong>Results: </strong>Participants had a mean (SD) age of 30 (5) years; 42% identified as non-Hispanic White, 25% as non-Hispanic Black, and 26% as Hispanic. Approximately one-third of participants (37%) had a tubal sterilization by study follow-up; 11% reported using no method of contraception. Many participants reported optimal contraceptive counseling (61%) and optimal method satisfaction (65%). Optimal counseling was associated with higher odds of optimal method satisfaction (aOR 1.88, 95% CI 1.03-3.46, <i>p</i> = 0.04). This relationship was sustained across all individual counseling quality domains.</p><p><strong>Conclusions: </strong>Patient-perceived provider demonstration of respect, discussion of contraceptive pros and cons, avoidance of pressure, and answering questions were associated with postpartum contraceptive method satisfaction.</p>","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"15409996261449180"},"PeriodicalIF":0.0,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147857976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"American Medical Women's Association Position Statement on Period Poverty: Advancing Menstrual Equity Through Health Coverage Reform.","authors":"Rhea Manohar, Meghan Etsey, Leah Liszak, Mallory Johnson, Vaishnavi J Patel, Devki Patel, Ariela L Marshall, Brianna Clark, Rosy Thachil, Roberta Gebhard","doi":"10.1177/15409996261449999","DOIUrl":"https://doi.org/10.1177/15409996261449999","url":null,"abstract":"<p><p>One in four persons with a uterus is unable to afford menstrual products, with even higher prevalence among low-income populations, an unmet need that contributes to preventable infections, missed school and work, and persistent health inequities. Despite the essential role of menstrual products in basic health and hygiene, many public health coverage programs across the United States, including Medicaid and other assistance programs, continue to exclude items such as pads and tampons. This gap disproportionately harms individuals who already face significant economic and health disparities. Although Flexible Spending Accounts and Health Savings Accounts now permit the use of funds for menstrual products, these mechanisms primarily benefit individuals with stable employment and disposable income, leaving the most vulnerable populations unprotected. Continued exclusion by insurance and assistance programs imposes an unnecessary financial and health burden and undermines dignity and well-being. Federal and state policymakers, including Congress, the Centers for Medicare & Medicaid Services, and state Medicaid agencies, have clear authority to address this inequity by expanding definitions of \"durable medical equipment\" and \"hygiene supplies\" to explicitly include menstrual products and by removing administrative barriers to coverage. The American Medical Women's Association calls for federal action to classify menstrual products as essential health services under Medicaid and other public assistance programs.</p>","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"15409996261449999"},"PeriodicalIF":0.0,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147857995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Female Predominance in Carotid Artery Dissection: Insights into Sex-Based Differences in Arteriopathies.","authors":"Fadi Elias Shamoun, Paru David, Suneela Vegunta","doi":"10.1177/15409996261448702","DOIUrl":"https://doi.org/10.1177/15409996261448702","url":null,"abstract":"","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"15409996261448702"},"PeriodicalIF":0.0,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147849307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Examining the Quality of Contraceptive Care Delivered Through Telehealth in a National Network of Reproductive Health Centers.","authors":"Hannah R Simons, Shivani Kochhar, Shweta Athilat","doi":"10.1177/15409996261439632","DOIUrl":"https://doi.org/10.1177/15409996261439632","url":null,"abstract":"<p><strong>Objective: </strong>With the onset of COVID-19 disruptions in the United States, Planned Parenthood rapidly expanded telehealth services to meet patient needs. This study examines patient and visit characteristics associated with telehealth use and compares the quality of contraceptive care delivered to telehealth and in-person patients.</p><p><strong>Methods: </strong>This cross-sectional study consisted of an electronic postvisit survey (<i>N</i> = 506, 2022) and a secondary analysis of electronic health record data from telehealth and in-person contraceptive patients (<i>N</i> = 59,691, 2020-2021) at five Planned Parenthood affiliates. We collected data on patient demographic characteristics, visit characteristics, and six dimensions of high-quality care from the Institute of Medicine's framework. We conducted bivariate (for the relationships between patient/visit characteristics and telehealth use) and multivariable modified Poisson regression (for the relationships between modality and multiple quality of care measures), adjusting for patient and visit characteristics (where appropriate).</p><p><strong>Results: </strong>Patients who preferred Spanish or another language were less likely to have a telehealth visit compared with patients who preferred English (prevalence ratio [PR] = 0.45, 95% confidence interval [CI]: 0.29-0.67; PR = 0.26, 95% CI: 0.13-0.56, respectively). Patients who had a birth control-only visit were more likely to have a telehealth visit compared with patients who had a visit for birth control and other services (PR = 0.12, 95% CI: 0.05-0.25). A higher percentage of telehealth patients choose birth control pills than in-person patients (81% versus 54%; PR = 2.91, 95% CI: 1.81-4.70). We found no statistically significant differences in effectiveness, person-centeredness, safety, and equity. Telehealth patients were less likely to have a cycle time (time from appointment check-in to check-out) of ≥60 minutes (adjusted prevalence ration [aPR] = 0.07, 95% CI: 0.04-0.14) and a wait time of ≥10 minutes (aPR = 0.18, 95% CI: 0.09-0.34) than in-person patients.</p><p><strong>Conclusion: </strong>Our findings suggest that contraceptive care delivered through telehealth provides comparably high quality as in-person care. Telehealth care may offer benefits in the ease and speed of scheduling and attending appointments.</p>","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"15409996261439632"},"PeriodicalIF":0.0,"publicationDate":"2026-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147849196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cancer Prevention in Women with Sickle Cell Disease: A Scoping Review of HPV Vaccination and Cancer Screening.","authors":"Canan D Dirican, Samer Jumean, Gurneel Dhanesar, Michael Maroules","doi":"10.1177/15409996261449176","DOIUrl":"https://doi.org/10.1177/15409996261449176","url":null,"abstract":"<p><strong>Background: </strong>Advances in sickle cell disease (SCD) care have substantially improved survival. This resulted in a growing population of adult women for whom cancer prevention is increasingly relevant. Female-specific cancer prevention strategies, including human papillomavirus (HPV) vaccination, cervical cancer screening, and breast cancer screening, are well-established in the general population. However, their implementation among women with SCD remains poorly characterized.</p><p><strong>Methods: </strong>We conducted a scoping review of PubMed and Embase from inception through January 2026 to identify studies, evaluating HPV vaccination, cervical cancer screening, or breast cancer screening among individuals with SCD. Observational and interventional studies reporting screening uptake, vaccination rates, or cervical HPV prevalence were included. Data were synthesized descriptively given the limited and heterogeneous nature of available evidence.</p><p><strong>Results: </strong>Eight studies met inclusion criteria. Across studies the uptake of HPV vaccination and cancer screening was variable but consistently suboptimal relative to the general population. HPV vaccination completion rates among adolescents and young adults with SCD did not exceed 50% in most cohorts, although targeted system-level interventions were associated with meaningful improvements. Data on cervical cancer screening were extremely limited, with only one study reporting high-risk HPV prevalence among adult women with SCD. Evidence on breast cancer screening was similarly sparse. The adherence to recommended screening intervals was inconsistent, and a high prevalence of dense breast tissue was reported. Overall, findings highlight fragmented delivery of preventive oncology services and substantial gaps in evidence, particularly in adult populations and high-income settings.</p><p><strong>Conclusions: </strong>Women with SCD experience significant gaps in HPV vaccination and cancer screening, despite increasing survival and frequent health care contact. The scarcity of high-quality data limits understanding of screening adherence, disparities, and downstream outcomes. Integrating preventive oncology into SCD care and prioritizing population-based research are essential to address missed opportunities and ensure equitable cancer prevention for this growing population.</p>","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"15409996261449176"},"PeriodicalIF":0.0,"publicationDate":"2026-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147849182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Postpartum Coverage Gap for Undocumented Immigrant Women.","authors":"Jesus Ruiz","doi":"10.1177/15409996261423420","DOIUrl":"10.1177/15409996261423420","url":null,"abstract":"","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"438-439"},"PeriodicalIF":0.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146129219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intrauterine Device Expulsion After Medication Versus Procedural Management of Induced and Spontaneous Abortion: A Retrospective Study.","authors":"Kyler McVay, Jenna Snyder, Nathanael Koelper, Andrea H Roe","doi":"10.1177/15409996251410003","DOIUrl":"10.1177/15409996251410003","url":null,"abstract":"<p><strong>Objective: </strong>To compare intrauterine device (IUD) expulsion rates between medication and procedural abortion management for induced or spontaneous abortion and identify risk factors for expulsion.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of patients undergoing medication or procedural management of induced or spontaneous abortion ≤10 weeks' gestation at a specialty clinic within a single academic center between 2010 and 2023. Included patients received a copper or levonorgestrel IUD at the time of uterine aspiration or within 30 days of medication management and had clinical or radiographical follow-up describing the IUD. The primary outcome was partial or complete IUD expulsion. Secondary analyses examined associations between clinical variables and expulsion risk.</p><p><strong>Results: </strong>Among 410 patients, 60 received medication for induced or spontaneous abortion, and 350 underwent procedural management for induced or spontaneous abortion. The IUD expulsion rate was 12% following medication management and 11% following procedural management, with no statistically significant difference. In a regression analysis, indication, treatment method, gestational age, and IUD type were not associated with IUD expulsion. Gravidity was the only independent risk factor (OR: 1.21; 95% CI: 1.09-1.35).</p><p><strong>Conclusions: </strong>IUD expulsion rate after procedural or medication management of induced or spontaneous abortion was approximately 11% and did not differ by indication or treatment.</p>","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"492-496"},"PeriodicalIF":0.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}